ArticleFrontiers in microbiology2026
Kinetics of foot-and-mouth disease antibody response in cattle vaccinated with FMD-HS-BQ combined vaccine under field condition.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Foot-and-mouth disease (FMD), Hemorrhagic septicemia (HS), and Black quarter (BQ) are economically important diseases of livestock and wildlife species worldwide, with vaccination serving as the primary control strategy. This study examined the development and duration of FMD antibody responses in cattle administered a trivalent FMD-HS-BQ vaccine under field conditions. Thirty cattle were allocated to three groups: Group 1 consisted of naïve calves (6 receiving a booster vaccination and 6 without a booster); Group 2 included adult cattle with an unknown vaccination history (6 with a booster, 6 without a booster); and Group 3 served as unvaccinated controls (6 animals). Blood samples were collected on days 0, 28, 120, 240, and 365 following initial vaccination, and anti-FMDV antibody levels were measured using solid-phase competitive ELISA. The combined vaccine stimulated anti-structural protein antibody production against FMDV in cattle, with antibodies remaining detectable through day 365 and beyond in animals receiving booster vaccination. Conversely, antibody levels in non-boosted animals started declining after day 120. Virus neutralization testing confirmed the presence of protective neutralizing antibodies on day 365 in cattle that received booster doses. These findings suggest that regular administration of the FMD-HS-BQ combined vaccine at wildlife-livestock interfaces could provide effective FMD protection while offering economic advantages through reduced vaccination costs, labor requirements, and stress on both animals and handlers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.